Capivasertib-induced diabetic ketoacidosis in a patient with stage IV breast cancer: A case report
This case report provides evidence of extreme insulin resistance in a patient treated with capivasertib. Guidance on the management of acute hyperglycemia secondary to capivasertib is not currently established, and further research on optimal management of these acute crises is needed.
Authors
- John Alfred Carr (ORCID: https://orcid.org/0000-0001-7357-7853)
- Paul S. Mueller
- Zoanne Harlas
Institutions
- WellStar Health System (US)
- University of Georgia (US)
- Augusta University Health (US)
- St. Joseph’s Candler Hospital (US)
Publication Details
- Journal
- American Journal of Health-System Pharmacy
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1093/ajhp/zxaf312
- Citations
- 1
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.81